Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00396240
Status:
WITHDRAWN
Last Update Posted:
2009-03-26
First Post:
2006-11-03
Brief Title:
ORBITAL Open-Label Primary Care Study Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals
Sponsor:
AstraZeneca
Organization:
AstraZeneca